The cancer therapeutics market size is expected to reach US$ 5,31,538.02 million by 2031 from US$ 2,30,423.56 million in 2024. The market is estimated to record a CAGR of 12.8% from 2025 to 2031.

Executive Summary and Global Market Analysis

The global cancer therapeutics market is experiencing significant expansion, primarily driven by the rising prevalence of breast and lung cancers and substantial investments in oncology research and development. Cancer therapeutics encompass a diverse array of treatments designed to combat or cure cancer. Key therapeutic approaches include chemotherapy, radiation therapy, immunotherapy, targeted therapy, hormone therapy, surgical interventions, and stem cell therapy. The main goal of these strategies is to eradicate or control cancerous cells, alleviate symptoms, and ultimately improve patient quality of life and survival rates. Treatment plans frequently involve a combination of multiple therapies, carefully tailored to the specific type and stage of cancer, as well as the patient's overall health, to achieve optimal outcomes.

Cancer Therapeutics Market Segmentation Analysis

The cancer therapeutics market is divided into three key segments: therapy type, indication, and distribution channel.

By therapy type, the market is categorized into chemotherapy, targeted therapy, radiation therapy, hormone therapy, and other therapeutic approaches. Chemotherapy held the largest market share in 2024.

Regarding indications, the market covers blood cancer, lung cancer, breast cancer, colorectal cancer, prostate cancer, stomach cancer, cervical cancer, liver and intrahepatic bile duct cancer, thyroid cancer, and other specific indications. Lung cancer represented the largest share of the market in 2024.

In terms of distribution channel, the market segments are hospital pharmacies, retail pharmacies, and online stores. Hospital pharmacies maintained the largest market share in 2024.

Download our Sample PDF Report

@ https://www.businessmarketinsights.com/sample/BMIRE00031299

Cancer Therapeutics Market Drivers and Opportunities

According to the World Health Organization, various forms of cancer are responsible for approximately 1 in every 6 deaths globally. In 2022, there were an estimated 20 million new cancer diagnoses and 9.7 million cancer-related deaths. This disease burden is projected to increase by approximately 77% by 2050, which will put significant pressure on global healthcare systems and communities. The American Cancer Society reports that 5–10% of all cancers are inherited from parental lineage. A substantial number of genes associated with cancer predisposition have been identified. For example, mutations in hereditary cancer susceptibility genes such as BRCA1 and BRCA2 significantly increase the risk of developing various cancers, including breast, ovarian, and prostate cancer. Breast cancer is globally recognized as the most prevalent cancer among women, with its incidence continuously rising due to contributing factors like environmental exposure, genetic susceptibility, hormonal imbalances, and evolving lifestyle choices. Additionally, breast cancer remains one of the most frequently diagnosed cancers in the U.S.

Cancer Therapeutics Market Size and Share Analysis

Based on therapy type, the cancer therapeutics market is segmented into chemotherapy, targeted therapy, radiation therapy, hormone therapy, and other therapy types. The chemotherapy segment held the dominant market position in 2024. Chemotherapy agents, through their cytotoxic action, effectively halt or slow the proliferation of cancer cells. These drugs are systemically delivered via the bloodstream, targeting and disrupting cancer cell growth throughout the body. According to National Institutes of Health estimates, approximately 650,000 cancer patients in the US undergo chemotherapy treatment annually in specialized oncology clinics.

Concerning indications, the market is segmented into blood cancer, lung cancer, breast cancer, colorectal cancer, prostate cancer, stomach cancer, cervical cancer, liver and intrahepatic bile duct cancer, thyroid cancer, and other indications. The lung cancer segment commanded the largest share of the market in 2024.

About Us:

Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications